In MPN-BP, studies of a JAK2V617F/TP53-mutant MPN-BP mouse model demonstrated that the leukemic clone appeared to arise from an aberrant megakaryocyte-erythrocyte progenitor (MEP) cell population (12). The gene discussed is TP53; the disease is myeloproliferative neoplasm.